Prognostic biomarkers in colorectal cancer with emphasis on microRNA
Metadata
Show metadataAppears in the following Collection
- Institutt for klinisk medisin [10814]
Abstract
No abstract.List of papers
Paper I: Schee K, Flatmark K, Holm R, Boye K, Paus E. Investigation of nonspecific cross-reacting antigen 2 as a prognostic biomarker in bone marrow plasma from colorectal cancer patients. Tumour Biol. 2012 Feb;33(1):73-83 Tumour Biol. 2012 Feb;33(1):73-83. Epub 2011 Oct 18. The paper is removed from the thesis in DUO due to publisher restrictions. The published version is available at: https://doi.org/10.1007/s13277-011-0247-5 |
Paper i: Schee K, Flatmark K, Holm R, Boye K, Paus E. Erratum to: Investigation of nonspecific cross-reacting antigen 2 as a prognostic biomarker in bone marrow plasma from colorectal cancer patients. Tumour Biol. 2012 Aug;33(4):1263. The paper is removed from the thesis in DUO due to publisher restrictions. The published version is available at: https://doi.org/10.1007/s13277-012-0407-2 |
Paper II: Schee K, Boye K, Abrahamsen TW, Flatmark K. Clinical relevance of miR-21, miR-31, miR92a, miR-101, miR-106a and miR-145 in colorectal cancer. Manuscript, published in: BMC Cancer. 2012 Nov 2;12:505. Published under the terms of the Creative Commons Attribution License The published version of this paper is available at: https://doi.org/10.1186/1471-2407-12-505 |
Paper III: Schee K, Lorenz S, Molton Worren M, Günther C-C, Holden M, Hovig E, Fodstad Ø, Meza- Zepeda L, Flatmark K. Deep sequencing the miRNA transcriptome in colorectal cancer. Manuscript version. PLoS One. 2013 Jun 18;8(6):e66165. Published under the terms of the Creative Commons Attribution License. The published version of this paper is available at: https://doi.org/10.1371/journal.pone.0066165 |